Cardio-spect

DB14106ApprovedInvestigationalSmall molecule

Tetrakis (2-methoxyisobutylisocyanide) copper (I) tetrafluoroborate is a component of Cardiolite, a technetium Tc99m-based imaging agent used for assessing myocardial perfusion.

Chemical structure of Cardio-spect
Formula / weight
C24H44BCuF4N4O4 · 602.99 g/mol (avg)
First approval
United States, 1990
Also known as
Tetrakis (2-methoxyisobutyl isonitrile) copper (I) tetrafluoroborate
Brand names
  • Cardiolite

Resolves to

Compound
UNIIN6OU7HJ70PCAS103694-84-4
Clinical / RWD
RxNorm1306061
Structure
InChIKeyWJRFSUVOHUMYAO-UHFFFAOYSA-NSMILES[Cu+].F[B-](F)(F)F.COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-].COC(C)(C)C[N+]#[C-]

What you can answer from here — as of April 02, 2025

5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
25Marketed productsAcross 7 countries and 17 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Cardio-spect, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In